It is possible that Hes1 upregulation following IM exposure in CML cells may also activate the PI3K/AKT pathway and confer anti-apoptotic signals to CML cells regardless of the BCR-ABL repressed activity (Fig 11a). This evidence concerns the gene HES1 and chronic myelogenous leukemia, BCR-ABL1 positive.